Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-60.41%
0%
-60.41%
6 Months
-63.02%
0%
-63.02%
1 Year
-66.61%
0%
-66.61%
2 Years
-92.94%
0%
-92.94%
3 Years
-95.89%
0%
-95.89%
4 Years
-97.1%
0%
-97.1%
5 Years
-96.74%
0%
-96.74%
Biosynex SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.98%
EBIT Growth (5y)
-214.52%
EBIT to Interest (avg)
42.11
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0.63
Sales to Capital Employed (avg)
1.27
Tax Ratio
3.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
66.25%
ROE (avg)
23.98%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.16
EV to EBIT
-2.36
EV to EBITDA
-65.04
EV to Capital Employed
0.48
EV to Sales
0.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-20.49%
ROE (Latest)
-41.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
196.60
382.50
-48.60%
Operating Profit (PBDIT) excl Other Income
55.20
147.30
-62.53%
Interest
0.60
0.40
50.00%
Exceptional Items
0.10
-0.70
114.29%
Consolidate Net Profit
15.70
104.00
-84.90%
Operating Profit Margin (Excl OI)
197.70%
367.70%
-17.00%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is -48.60% vs 148.54% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is -84.90% vs 231.21% in Dec 2021
About Biosynex SA 
Biosynex SA
Pharmaceuticals & Biotechnology
Biosynex SA is a France-based company that specializes in the research, development and manufacture of in-vitro diagnostic kits aimed at health professionals. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). It operates through Fumouze Diagnostics and SR2B.
Company Coordinates 
Company Details
22 Boulevard Sebastien Brant , ILLKIRCH-GRAFFENSTADEN None : 67400
Registrar Details






